Cell and Gene Therapy, alongside broader biotechnological innovations, are transforming modern medicine. Their highly complex structures and manufacturing processes, however, demand rigorous analytical, technical, operational, regulatory and compliance frameworks to ensure safety, quality and reliability.
At Cytologicx, we specialize in delivering tailored GMP/GxP services for biologics, biosimilars, cell and gene therapy products, pharmaceuticals and medical devices.Our support enables biotechnology companies to navigate development and commercialization with greater speed, precision and compliance, ultimately reducing time to market.
Our experienced scientific excellence teams operate under established regulatory standards, including GMP/GxP, FDA, USP, and PIC/S requirements. By combing deep technical expertise with robust compliance practices, Cytologicx provides end-to-end support that empowers innovators to bring advanced therapies to patients safely and efficiently.
Achieving GMP/GxP compliance requires scientific depth, operational experience and a clear understanding of global regulatory expectations. As a team of senior GMP/GxP consultants with strong scientific backgrounds and extensive industry and regulatory expertise – including experience with the FDA and EMA – we bring proven capability to every engagement.
With more than 2500 GMP/GxP projects completed worldwide, we offer practical, targeted support that helps organizations strengthen compliance, improve quality systems and meet regulatory requirements with confidence.
Our services are flexible and fully customizable ranging from focused expert input to broader strategic collaboration. We work closely with your teams to deliver solutions that are realistic, efficient and aligned with your operational needs.
We understand the challenges you face on the path to compliance. Together, we can develop practical, achievable and cost-effective solutions that help you reach your goals quickly and safely.
At Cytologicx, we are dedicated to ensuring that innovative medicines reach patients safely, reliably and on time. Our expertise covers the full spectrum of Biologics and Advanced Therapies, including monoclonal antibodies, ADCs, biosimilars, cell and gene therapies and all vaccine types.
Whether at the bench or in the boardroom, we deliver excellence through our specialized practices, supporting organizations from start-ups to global multinationals. We ensure therapies meet the highest regulatory and technical standards, so patients receive the right treatment when they need it.
Through our client-focused approach, we combine expertise and guidance to strengthen capabilities, compliance, and patient-centric delivery across every stage of development and production.
Cytologicx offers high-quality Excellence Services divided into three key areas:
tailored guidance to e.g. optimize processes utilizing proven technological advancement (e.g. AI, 3D, Blockchain, Cybersecurity, Augmented and Virtual Reality ) and enhance quality
comprehensive assessments and simulated inspections to ensure compliance with the highest standards and best practices.
practical, interactive programs to keep your teams up-to-date with the latest techniques and regulations.
